Lemsip Cough & Cold Capsules with Caffeine
- Name:
Lemsip Cough & Cold Capsules with Caffeine
- Company:
Reckitt Benckiser Ireland Limited
- Active Ingredients:
- Legal Category:
Supply through general sale
Patient Information Leaflet Patient Information Leaflet last updated on medicines.ie: 15/01/20


Print ViewKeyword Search SPC
1. NAME OF THE MEDICINAL PRODUCT
1. NAME OF THE MEDICINAL PRODUCT
2. QUALITATIVE AND QUANTITATIVE COMPOSITION
2. QUALITATIVE AND QUANTITATIVE COMPOSITION
3. PHARMACEUTICAL FORM
3. PHARMACEUTICAL FORM
4. CLINICAL PARTICULARS
4. CLINICAL PARTICULARS
5. PHARMACOLOGICAL PROPERTIES
5. PHARMACOLOGICAL PROPERTIES
6. PHARMACEUTICAL PARTICULARS
6. PHARMACEUTICAL PARTICULARS
7. MARKETING AUTHORISATION HOLDER
7. MARKETING AUTHORISATION HOLDER
8. MARKETING AUTHORISATION NUMBER(S)
8. MARKETING AUTHORISATION NUMBER(S)
9. DATE OF FIRST AUTHORISATION/RENEWAL OF THE AUTHORISATION
9. DATE OF FIRST AUTHORISATION/RENEWAL OF THE AUTHORISATION
10. DATE OF REVISION OF THE TEXT
10. DATE OF REVISION OF THE TEXT
Reckitt Benckiser Ireland Limited

Company Products
When a pharmaceutical company changes any document, a new version is published on medicines.ie. For each version, we show the dates it was published on medicines.ie and the reasons for change.
Updated on 15 January 2020 PIL
Reasons for updating
- Change to section 6 - manufacturer
Updated on 12 January 2015 SPC
Reasons for updating
- New SPC for new product
Legal category: Supply through general sale
Updated on 12 January 2015 SPC
Reasons for updating
- Change to section 3 - Pharmaceutical form
- Change to section 6.1 - List of excipients
Legal category: Supply through general sale
Free text change information supplied by the pharmaceutical company
Updated on 10 February 2014 SPC
Reasons for updating
- Change to section 6.5 - Nature and contents of container
Legal category: Supply through general sale
Free text change information supplied by the pharmaceutical company
Section 10 - Updated Date of Revision to December 2013
Updated on 19 October 2012 PIL
Reasons for updating
- New PIL for new product
Updated on 19 October 2012 PIL
Reasons for updating
- Change due to user-testing of patient information
Updated on 13 March 2012 PIL
Reasons for updating
- Change to warnings or special precautions for use
- Change of contraindications
Updated on 27 July 2011 SPC
Reasons for updating
- Change to section 4.3 - Contraindications
- Change to section 4.2 - Posology and method of administration
Legal category: Supply through general sale
Free text change information supplied by the pharmaceutical company
Not recommended for children under 6 years of age.
The following text has been added; Not recommended for children under 12 years of age.
Section 4.3 the following text has been added ; Contraindictaed in children under 12 years of age
Updated on 30 March 2011 SPC
Reasons for updating
- Change to section 3 - Pharmaceutical form
- Change to section 10 - Date of revision of the text
Legal category: Supply through general sale
Free text change information supplied by the pharmaceutical company
In section 10, Revision of text updated to May 2010
Updated on 30 March 2011 PIL
Reasons for updating
- Change to date of revision
- Change to appearance of the medicine
Updated on 19 October 2009 PIL
Reasons for updating
- New PIL for new product
Updated on 31 July 2009 SPC
Reasons for updating
- New SPC for new product
Legal category: Supply through general sale